Research Brief
Reviewing the returns of research: Capturing payback from funding by the Arthritis Research Campaign
Jan 12, 2007
Format | File Size | Notes |
---|---|---|
PDF file | 1.7 MB | Use Adobe Acrobat Reader version 10 or higher for the best experience. |
Format | File Size | Notes |
---|---|---|
PDF file | 0.2 MB | Use Adobe Acrobat Reader version 10 or higher for the best experience. |
There is increasing pressure for research funders to demonstrate, and seek to maximise, the payback from the research they fund. This report, prepared for and funded by the Arthritis Research Campaign (arc), presents the results of an evaluation of 16 research grants awarded by arc in the early 1990s. The main objective was to develop a system for evaluating arthritis research, with a view to allowing arc to stimulate and manage the exploitation of research advances so that they translate into outcomes of practical benefit to people with arthritis.
Volume 2 of the report presents a collection of the case studies used in the study. These case studies all follow a similar format based on the conceptual model and provide a rich and detailed narrative on the payback of each research grant.
Volume 1 of the report presents a framework that conceptualises the relationship between research inputs, process, output and outcomes. Using this framework, we catalogue a diverse range of research output and outcomes arising from these 16 grants and make a series of quantitative and qualitative assessments comparing, for example, payback from project grants versus programme grants. In conclusion, we make six observations:
Chapter One
Introduction
Chapter Two
Case Study A: Back Pain in Primary Care — Assessment of Exercise-Based Management
Chapter Three
Case Study B: Occupational Activity and Hip Osteoarthritis — A Case Control Study
Chapter Four
Case Study C: A Comparison of the Tissue Inhibitors of Metalloproteases TIMPs 1 and 2 by Biochemical and Biological Approaches
Chapter Five
Case Study E: Osteoarthritis of the Knee Joint — Risk Factors, Process and Outcome
Chapter Six
Case Study F: The Molecular and Cell Biology of Collagen X and Its Relation to Human Disease
Chapter Seven
Case Study G: Interaction between Complement, Immune Complexes and the Mononuclear Phagocytic System
Chapter Eight
Case Study H: Lymphocyte Differentiation and Function in Rheumatoid Arthritis
Chapter Nine
Case Study I: The Pathophysiology of Muscle in Osteoarthritis
Chapter Ten
Case Study J: Proprioceptive Rehabilitation of the Anterior Cruciate Ligament Deficient Patient
Chapter Eleven
Case Study K: A Prospective Randomised Theraputic Trial of Lowdose Aspirin Versus Aspirin Plus Low-Dose Subcutaneous Heparin
Chapter Twelve
Case Study L: The Kennedy Institute Core Grant
Chapter Thirteen
Case Study M: Mapping and Characterisation of the Genes Involved in Rheumatoid Arthritis
Chapter Fourteen
Case Study N: The Kennedy Institute Core Grant
Chapter Fifteen
Case Study O: Identification of Non-HLA Rheumatoid Arthritis Susceptibility Gene
Chapter Sixteen
Case Study P: The Norfolk Arthritis Register (NOAR)
Appendix A
Bibliometrics Results Tables
Appendix B
Assessors’ Report Form
The research described in this report was prepared for and funded by the Arthritis Research Campaign (arc) and performed by RAND Europe.
This report is part of the RAND Corporation Technical report series. RAND technical reports may include research findings on a specific topic that is limited in scope or intended for a narrow audience; present discussions of the methodology employed in research; provide literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research professionals, and supporting documentation; or deliver preliminary findings. All RAND reports undergo rigorous peer review to ensure that they meet high standards for research quality and objectivity.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.